Tumor cell identification and classification in esophageal adenocarcinoma specimens by hyperspectral imaging

Sci Rep. 2022 Mar 16;12(1):4508. doi: 10.1038/s41598-022-07524-6.

Abstract

Esophageal cancer is the sixth leading cause of cancer-related death worldwide. Histopathological confirmation is a key step in tumor diagnosis. Therefore, simplification in decision-making by discrimination between malignant and non-malignant cells of histological specimens can be provided by combination of new imaging technology and artificial intelligence (AI). In this work, hyperspectral imaging (HSI) data from 95 patients were used to classify three different histopathological features (squamous epithelium cells, esophageal adenocarcinoma (EAC) cells, and tumor stroma cells), based on a multi-layer perceptron with two hidden layers. We achieved an accuracy of 78% for EAC and stroma cells, and 80% for squamous epithelium. HSI combined with machine learning algorithms is a promising and innovative technique, which allows image acquisition beyond Red-Green-Blue (RGB) images. Further method validation and standardization will be necessary, before automated tumor cell identification algorithms can be used in daily clinical practice.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma* / diagnostic imaging
  • Artificial Intelligence
  • Carcinoma, Squamous Cell*
  • Esophageal Neoplasms* / diagnostic imaging
  • Humans
  • Hyperspectral Imaging

Supplementary concepts

  • Adenocarcinoma Of Esophagus